Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. From Wikipedia
HIV and liver disease drug sales bolstered earnings, while oncology, COVID antiviral, and cell therapy segments underperformed, prompting reaffirmation of full-year guidance.
